OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity
Ryan A. Heiser, Anthony Cao, Weiping Zeng, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 1, pp. 68-83
Open Access | Times Cited: 12
Ryan A. Heiser, Anthony Cao, Weiping Zeng, et al.
Molecular Cancer Therapeutics (2023) Vol. 23, Iss. 1, pp. 68-83
Open Access | Times Cited: 12
Showing 12 citing articles:
Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Yiman Han, Xin Tian, Jiaqi Zhai, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 9
Antibody–Drug Conjugates Targeting CD30 in T-Cell Lymphomas: Clinical Progression and Mechanism
Yi Jiang, Sai Dong, Yang Wang
Cancers (2025) Vol. 17, Iss. 3, pp. 496-496
Open Access
Yi Jiang, Sai Dong, Yang Wang
Cancers (2025) Vol. 17, Iss. 3, pp. 496-496
Open Access
Current Issues and Future Perspectives of Targeted Therapies in Primary Mediastinal Large B-Cell Lymphoma
Athanasios Liaskas, Maria Dimopoulou, Alexia Piperidou, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1191-1191
Open Access
Athanasios Liaskas, Maria Dimopoulou, Alexia Piperidou, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1191-1191
Open Access
The effectiveness and safety of RC48 alone or in combination with PD-1 inhibitors for locally advanced or metastatic urothelial carcinoma: a multicenter, real-world study
Hongyan Ge, Changxue Liu, Chengquan Shen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Hongyan Ge, Changxue Liu, Chengquan Shen, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas
Rana R. McKay, Renu Eapen, Elizabeth Wulff‐Burchfield, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Rana R. McKay, Renu Eapen, Elizabeth Wulff‐Burchfield, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre study
Yujia Huo, Shu Cheng, Hongmei Yi, et al.
EBioMedicine (2025) Vol. 115, pp. 105693-105693
Closed Access
Yujia Huo, Shu Cheng, Hongmei Yi, et al.
EBioMedicine (2025) Vol. 115, pp. 105693-105693
Closed Access
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate
Elena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Elena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Novel bispecific antibody-drug conjugate targeting PD-L1 and B7-H3 enhances antitumor efficacy and promotes immune-mediated antitumor responses
Yijun Dong, Zongliang Zhang, Siyuan Luan, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009710-e009710
Open Access | Times Cited: 3
Yijun Dong, Zongliang Zhang, Siyuan Luan, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e009710-e009710
Open Access | Times Cited: 3
Targeted Drug Delivery by MMAE Farnesyl-Bioconjugated Multivalent Chemically Self-Assembled Nanorings Induces Potent Receptor-Dependent Immunogenic Cell Death
Yiao Wang, Ozgun Kilic, Lakmal Rozumalski, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 5, pp. 582-592
Closed Access | Times Cited: 2
Yiao Wang, Ozgun Kilic, Lakmal Rozumalski, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 5, pp. 582-592
Closed Access | Times Cited: 2
How Immunotherapy Has Redefined the Treatment Paradigm of Metastatic or Locally Advanced Muscle-Invasive Urothelial Bladder Carcinoma
Mathieu Larroquette, Félix Lefort, Charlotte Domblides, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1780-1780
Open Access | Times Cited: 2
Mathieu Larroquette, Félix Lefort, Charlotte Domblides, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1780-1780
Open Access | Times Cited: 2
Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy
Xiao Hua Xie, Ming Yang, Wei Xue, et al.
Acta Biomaterialia (2024) Vol. 189, pp. 532-544
Closed Access | Times Cited: 2
Xiao Hua Xie, Ming Yang, Wei Xue, et al.
Acta Biomaterialia (2024) Vol. 189, pp. 532-544
Closed Access | Times Cited: 2
Antibody-Based Therapies for Peripheral T-Cell Lymphoma
Nazila Shafagati, Suman Paul, Sima Rozati, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3489-3489
Open Access | Times Cited: 2
Nazila Shafagati, Suman Paul, Sima Rozati, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3489-3489
Open Access | Times Cited: 2
Exogenous or in situ vaccination to trigger clinical responses in pancreatic cancer
Gregory L. Beatty, Elizabeth M. Jaffee
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 826-835
Closed Access | Times Cited: 1
Gregory L. Beatty, Elizabeth M. Jaffee
Carcinogenesis (2024) Vol. 45, Iss. 11, pp. 826-835
Closed Access | Times Cited: 1
CD19+CD73+ B cells infiltration indicates poor prognosis and unfavorable responses to immunotherapy in gastric cancer
Yawei Zhang, Wendong Wang, Qi Liu, et al.
International Immunopharmacology (2024) Vol. 141, pp. 113002-113002
Closed Access
Yawei Zhang, Wendong Wang, Qi Liu, et al.
International Immunopharmacology (2024) Vol. 141, pp. 113002-113002
Closed Access
